Aaron L. Luebke

Aaron L. Luebke

Hematology | Oncology
701 E. Rosser Ave.
Bismarck, ND 58501

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

A pilot study of JI-101, an inhibitor of VEGFR-2, PDGFR-β, and EphB4 receptors, in combination with everolimus and as a single agent in an ovarian cancer expansion cohort.

A pilot study of JI-101, an inhibitor of VEGFR-2, PDGFR-β, and EphB4 receptors, in combination with everolimus and as a single agent in an ovarian cancer expansion cohort.

Journal: Investigational new drugs
Published: July 01, 2015
Showing 1-1 of 1

Last Updated: 09/26/2026